Mylan

This page summarises award records that name this supplier and the public buyers listed alongside it. Published names are joined when identifiers or close name matches support the link.

Award history

Published records by year

Each row counts award records linked to this supplier. A single procurement can produce more than one award.

Annual award records and published value assigned to this supplier
Year	Awards	Value counted	Values not counted
2025	4	Value not published	4
2024	4	Value not published	4
2023	3	Value not published	3
2022	1	Value not published	1

Buyer relationships

Buyer relationships by value counted

Ranked by published value assigned to this supplier, then by award count.

SupplierMylan

Source records

Published awards

19 records linked to this supplier.

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender
Buyer: NHS England
End date in notice
30 Apr 2029
Value shown in notice
£1,241,520,444Whole award value; not assigned to one supplier
Official source
Open the official Contracts Finder notice for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
View record references
Source
Contracts Finder
Award or lot reference
ocds-b5fd17-1063d704-a8da-4ec0-b11c-5b9fec849d60 / ocds-b5fd17-1063d704-a8da-4ec0-b11c-5b9fec849d60-1
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National
Buyer: NHS England

Mylan

Published records by year

Buyer relationships by value counted

Published awards

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS National Generic Pharmaceuticals - Clozapine

NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)

NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

NHS National Framework for Transition products commencing 1 May 2024

NHS National Generic Pharmaceuticals Wave 14b

NHS London Branded Medicines - Tranche B - September 2023

CM/PHR/22/5687 - NHS National Proprietary Low Molecular Weight Heparins

NHS Framework for the North of England, Branded Medicine

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025

Hospital Only Products

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025

Wave 15b - Hospital Only (Housekeeping) All regions

Wave 15b - Hospital Only DCE & DSW regions

Supply of Clozapine EXCLUDING Testing - All Regions

Supply of Clozapine INCLUDING Testing - All Regions